Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract : AIDS

Secondary Logo

Journal Logo


Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract

Manickam, Cordeliaa; Nwanze, Chiadikaa; Ram, Daniel R.a; Shah, Spandan V.a; Smith, Scotta; Jones, Rhiannaa; Hueber, Bradya; Kroll, Kylea; Varner, Valeriea; Goepfert, Paulb; Jost, Stephaniea; Reeves, R. Keitha,c

Author Information
AIDS 32(12):p 1571-1578, July 31, 2018. | DOI: 10.1097/QAD.0000000000001855



Recent studies have demonstrated that in addition to traditional adaptive features, multiple subpopulations of B cells may also exhibit innate functions. However, thus far much of what we know about so-named innate-like B cells (ILB) comes from studies carried out in mice. In mice, ILB fall under the broad classification of B1 cells, which are predominantly present in the pleural and peritoneal cavities and also include marginal zone B cells, and other related B-cell phenotypes [1,2]. Largely because of localization, ILB may be some of the first immune cells to come in contact with invading pathogens [2,3]. ILB have highly cross-reactive B-cell receptors and/or Toll like receptors that results in robust cytokine production and/or enhanced production of natural antibodies against virus and bacterial antigens [4–6]. ILB have also been shown to have immunoregulatory properties through the production of IL-10 [7]. Although characterization of ILB has proven to be challenging in humans, several studies looking at B cells in the blood have identified multiple memory CD5+IgM+ B-cell phenotypes that appear analogous to murine B1 cells [8–10]. Multiple studies have shown that phenotypic and functional B-cell abnormalities, including induction of a regulatory B-cell-like phenotype, are associated with HIV infection [11–15]. However, any role for ILB in HIV disease is largely unexplored.

Most recently, a novel subset of ILB has been identified in both humans and mice to share features of natural killer and B cells, and is an early source of multiple innate cytokines including IL-18 and IL-12 [16]. Natural killer-like B cells (NKB), like other ILB, also have semi-permanent expression of natural IgM, can activate natural killer and innate lymphoid cells following stimulation, and thus modulate a critical cascade of innate and adaptive immune responses eventually necessary to contain viral infections. However, Kerdiles et al.[17] questioned these findings and suggested that NKB in mice may not actually be a unique subset of B cell, but instead are just a subpopulation of conventional B cells. In rebuttal, Wang et al.[18] reported mRNA expression of genes encoding NK1.1 (klrb1c) and NKp46 (Ncr1) in murine NKB cells. In order to help clarify the existence of the proposed NKB population in higher primates, we investigated whether the putative phenotype exists in blood and tissues of humans and rhesus macaques, and if chronic HIV and simian immunodeficiency virus (SIV) infection may perturb this unique cell niche.


Macaque and human samples

Peripheral blood mononuclear cells (PBMC) and tissue mononuclear cells isolated from spleen, mesenteric lymph nodes (MLN), and colon of naive rhesus macaques (n = 18) were included in this study. PBMC and tissue mononuclear cells from spleen, colon, jejunum, MLN, oral lymph nodes (OLN), axillary lymph nodes (ALN), tonsils and jejunum from a chronically (140 days post challenge) SIVmac251-infected cohort (n = 13) were also included. All animals were housed at Biomere (Worcester, MA, AAALC number 1152). All study samplings were reviewed and approved by the Biomere Institutional Animal Care and Use Committee. All animal housing and studies were carried out in accordance with recommendations detailed in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health with recommendations of the Weatherall report: ‘The use of nonhuman primates in research.’ Animals were fed standard monkey chow diet supplemented daily with fruit and vegetables and water ad libitum. Social enrichment was delivered and overseen by veterinary staff and overall animal health was monitored daily. Animals showing significant signs of weight loss, disease or distress were evaluated clinically and then provided dietary supplementation, analgesics, and/or therapeutics as necessary. Humane euthanasia was carried with an overdose of pentobarbital using standard protocols.

A total of 17 (PBMC and/or spleens) persons were analyzed in this study and the median ages were 46 years among naive individuals and 39 years among untreated viremic HIV-positive patients. Both the University of Alabama at Birmingham and Harvard University Institutional Review Board (IRB) reviewed and gave approval for the studies herein and written informed consent was obtained from each of the study participants. Frozen mononuclear cells from human naive spleen samples were provided by Massachusetts General Hospital and approved by the local IRB.

Flow cytometric staining of mononuclear cells

Mononuclear cells were characterized using surface and intracellular markers to discriminate B cells, natural killer cells and NKB cells. Using polychromatic flow cytometry cross-reactive antibodies against the following antigens were included: IgA (goat polyclonal; Rockland Immunochemical, Pottstown, Philadelphia, USA), IgG (G18-145; BD Biosciences, San Jose, California, USA), IgM (G20-127; BD Biosciences), CD20 (2H7; BD Biosciences), CD40 (5C3; BD Biosciences), HLA-DR (IMMU-157; Beckman Coulter, Indianapolis, Indiana, USA), NKG2A (Z199; Beckman Coulter), NKp46 (BAB281; Beckman Coulter), CD56 (HCD56; Biolegend, San Diego, California, USA), CD16 (3G8; BD Biosciences), CD127 (eBIORDR5; Life Technologies, Carlsbad, California, USA), and CD3 (SP34.2; BD Biosciences). Briefly, 1–2 × 106 cells were first stained with Aqua dye for 30 min at room temperature for live/dead separation. Cells were washed and stained for surface markers at 4 °C for 30 min and then fixed using a 1% formaldehyde solution. Intracellular staining for granzyme B (GB11; BD Biosciences) was performed using Fix/Perm reagents (Thermo Fisher Scientific, Waltham, Massachusetts, USA) according to the manufacturer's suggested protocol. Fixed samples were acquired on an LSRII (BD Biosciences) and analyzed using FlowJo software (version 9.9.4; Treestar, Ashland, Oregon, USA). Multiparametric analyses were performed using SPICE (v. 5.3; National Institute of Health, Bethesda, Maryland, USA) [19].

After live lymphocyte gating, CD3CD20+CD127 cells were gated as B cells, CD3HLADRNKG2A+ cells as natural killer cells, and CD3CD20+CD127 NKG2A+cells as NKB cells in rhesus macaques; CD3NKG2ANKp46CD20+ as B cells, CD3NKG2A+/−NKp46+/−CD127 as natural killer cells and CD3NKG2A+/−NKp46+/−CD20+CD127 cells as NKB cells in human samples. Although samples were negatively gated for CD127 to exclude innate lymphoid cells [20], inclusion of CD127 expression on NKB did not alter the immunological profile.

RNA flow

Mononuclear cells were thawed and rested for 12 h in R10 media at 37 °C prior to surface and intracellular staining. RNA-flow hybridization was performed using the manufacturer's recommended protocol (PrimeFlow, Affymetrix, Santa Clara, California, USA) with the antibodies detailed in the flow cytometry section, and with rhesus macaque-specific KLRC1 and KLRC2 probesets. Rhesus-specific probesets were custom designed with the assistance of Affymetrix to target rhesus KLRC1 and KLRC2. Target probe sequences will be published elsewhere. Probesets were labeled with Alexa-488 (KLRC1) and Alexa-647 (KLRC2) fluorophores by Affymetrix. All KLRC1 and KLRC2 gates were determined per sample by comparing the samples stained with all antibodies and probesets with samples only stained with antibodies (no probeset control).

Virus quantification

Plasma HIV-1 RNA levels were determined using the Amplicor ultrasensitive HIV-1 monitor assay at UAB hospitals (version 1.5; Roche Diagnostics Systems, Indianapolis, Indiana, USA) [21]. SIV plasma RNA was quantified as described previously [22].

Statistical analysis

Statistical differences between normal and HIV/SIV infected samples were analyzed by nonparametric Mann−Whitney U-test and were performed using GraphPad Prism v. 7 (La Jolla, California, USA). Statistical differences between pies were calculated by Permutation test as described [19]. Differences between mean ranks were considered significant at P < 0.05.


Lymphocytes expressing phenotypic features of both natural killer and B cells are found in rhesus macaques

On the basis of NKB cell phenotyping in mice described by Wang et al.[16], we identified NKB as CD3CD20+NKG2A+ cells in rhesus macaques (Fig. 1a) and further characterized these cells for their surface expression of other B cell and natural killer cell-specific markers (Fig. 1b). NKB cells showed intermediate to low expression of HLA-DR and CD40, which are typically highly expressed on B cells but not on natural killer cells. NKB cells also expressed levels of the activating natural killer cell receptor NKp46 similar to rhesus macaque natural killer cells, but levels of the Fc receptor CD16 were notably intermediate compared to B cells (which were negative above background), but lower than the high CD16 expression found on natural killer cells in blood [23]. NKB cells also expressed unexpectedly high levels of intracellular granzyme B (Supplementary Fig 1, Overall, this initial characterization suggested a cell type that uniquely overlapped phenotypically between B cells and natural killer cells.

Fig. 1:
Phenotypic characterization of natural killer-like B cells in rhesus macaques.Flow cytometric representations of (a) gating strategy used for identifying NKB, natural killer, and B-cell populations and (b) comparative expression of markers to delineate NKB cells from natural killer, and B-cell markers by histogram overlay analysis. Plots are representative of over 30 animals. NKB, natural killer-like B cells.

To further confirm NKB cells as unique subset of B cells and to rule out nonspecific binding of natural killer-specific antibodies to B cells, we analyzed transcript expression of the natural killer genes NKG2A (KLRC1 mRNA) and NKG2C (KLRC2 mRNA) in spleen samples using RNA-flow. A minor subpopulation of B cells corresponding to NKB cells expressed KLRC1 and KLRC2 mRNA at similar density compared with natural killer cells (Fig. 2). In addition, these cells co-expressed natural killer cell-specific surface proteins NKG2A/C, CD2, NKp30 and CD16 thus confirming the NKB cell population genuinely expressing natural killer cell markers.

Fig. 2:
Expression of natural killer-cell-specific transcripts and proteins on a subpopulation of B cells.B cells (top row) and natural killer cells (bottom row) as identified in Fig. 1 were further gated for KLRC1 mRNA (NKG2A) and KLRC2 mRNA (NKG2C) using RNA flow. The left-most plots show B and natural killer cells that were stained in the absence of KLRC1 and KLRC2 probes (no probeset control, labeled ‘No probe’). The remaining plots correspond to representative samples showing KLRC1 vs. KLRC2 mRNA, which are shown in each quadrant. Density and distribution of several natural killer-cell-specific proteins (labeled as NKG2A, CD2, NKp30, CD16) as well as a non-natural killer cell protein (labeled HLA-DR) as measured by traditional flow cytometry are superimposed on these populations. The density of each indicated flow cytometry marker is illustrated by a heatmap from blue (low median expression) to red (high median expression). This sample is representative of six independent experiments.

Natural killer-like B cells are found systemically, but expand in the gastrointestinal tract during simian immunodeficiency virus infection

Wang et al.[16] describe NKB cells as unique innate cells that prime other innate and adaptive lymphocytes. Following identification in rhesus macaques, we next characterized the NKB cell population in multiple tissues of naive and chronically SIV-infected macaques. The frequency of NKB cells varied significantly in normal tissues with a median of 0.012% in PBMC, a median of 0.047% in MLN, a median of 0.015% in colon, and a median of 0.191% in spleens (Fig. 3). In SIV-infected macaques, NKB cells were significantly increased in PBMC and colon (Fig. 3a and d), but not in spleen or MLN (Fig. 3b and c). Although not specifically addressed between groups in this study, NKB cells were also found in OLN, ALN, tonsil, and jejunum of SIV-infected animals (Supplementary Fig 2, indicating their wide distribution. This particular cohort of SIV-infected macaques had a median viral load of 9.30 × 105 copies/ml, plasma (range, 4.17 × 104−4.05 × 107 copies), but there was no correlation between virus load and NKB frequencies. Further, the NKB cell phenotype was only partially modulated by SIV infection with significant upregulation of HLA-DR, CD16, CD40, and CD56 primarily restricted to spleen, but indicating a potential activation of these cells (Fig. 3E-H).

Fig. 3:
Elevated activated natural killer-like B-cell frequencies in simian immunodeficiency virus-infected macaques.Each data point represents percentages of NKB cells in (a) PBMC, (b) spleen, (c) mesenteric lymph nodes (MLN) and (d) colon of naive and chronically infected animals. Expression of natural killer and B-cell specific markers (e) HLA-DR, (f) CD56, (G) CD16, and (h) CD40 are shown for naive and SIV-infected macaques. Asterisks indicate significant differences between naive and infected animals analyzed by Mann−Whitney U-test. NKB, natural killer-like B cell; PBMC, peripheral blood mononuclear cells. * P < 0.05, ** P < 0.005, *** P < 0.0005.

Natural killer-like B cells are found in human tissues, but not peripherally expanded by HIV infection

To accommodate modest differences in phenotypic marker expression between human and macaque NK cells, we modified our gating strategy for human PBMC samples to identify NKB cells as CD3NKG2A+/−NKp46+/−CD20+CD127 (Fig. 4a). Otherwise, the NKB cell subset showed remarkable similarity to the rhesus macaque subpopulation with overlapping expression profiles for B cell and natural killer cell-specific markers (Fig. 4b), though more strikingly than in rhesus macaques (Fig. 1b) human NKB cells expressed CD40 and HLA-DR at levels comparable with B cells (Fig. 4b). The range of NKB cell frequencies in human PBMC and spleen were similar to what was observed in rhesus macaques (medians 0.012 and 0.011% of lymphocytes, respectively; Fig. 4c, Supplementary Fig 2, However, no significant differences in NKB frequencies were found between normal and HIV-infected/ART naive individuals (median viral load of 4.89 × 104 copies/ml, plasma; range, 2.30 × 104−3.41 × 105 copies/ml, plasma). The phenotypic profiles of human NKB cells were generally retained, but similar to what was observed in some rhesus macaque tissues there was an upregulation of CD56 (Fig. 4d).

Fig. 4:
Natural killer-like B cells in human peripheral blood mononuclear cells.(a) Representative gating strategy for delineating NKB populations in human PBMC, and (b) comparative expression of markers to delineate NKB cells from natural killer and B-cell markers by histogram overlay analysis. (c) Comparison of frequencies of NKB cells in normal and HIV-infected/ART-naive patients. Expression of natural killer and B-cell specific markers on NKB cells from both cohorts are shown (d). Asterisks indicate significant differences analyzed by Mann−Whitney U-test. NKB, natural killer-like B cell; PBMC, peripheral blood mononuclear cells. * P < 0.05, ** P < 0.005, *** P < 0.0005.

Surface immunoglobulin expression on natural killer-like B cells

As a more robust indicator to determine NKB cell similarities to true B cells, we next investigated the breadth of surface Ig expression in both normal and SIV-infected macaques and naive and HIV-1-infected humans. Notably, the proportion of NKB expressing any type of Ig was highly variable and appeared to be more stable in humans (3−87% in rhesus macaques, 59−99% in humans). However, the diversity of expression on positive cells revealed unique patterns (Fig. 5). Surface IgA and IgM were almost universally expressed in PBMC, spleen, and MLN of both species (up to 99% in humans), and these findings are very similar to the initial description of stable IgM on murine NKB cells and other ILB [16,24]. IgG was expressed at much lower levels in normal individuals, but increased up to 10-fold in spleen and MLN of SIV-infected macaques. In contrast, IgG upregulation was not observed in PBMC of HIV-infected persons.

Fig. 5:
Immunoglobulin expression on natural killer-like B cells in rhesus macaques and humans.Distribution frequencies of IgA, IgG, and IgM calculated using Boolean gates of Ig-positive samples averaged over 4−18 animals/human participants per group, depending on tissue, using SPICE (v.5.3). Shaded pie slices indicate individual populations and pie arcs show overlapping expression of Ig molecules. Statistical evaluations were made between normal and infected samples and P values as determined by permutations test are shown. NS, not significant.


Multiple lines of evidence suggest HIV and SIV infection may dysregulate B cell and natural killer cell functions [11–14,23,25–27]. Conversely, mobilization of anti-HIV/SIV antibodies is considered at the forefront of effective vaccination, alternative antivirals, and curative therapeutics against these diseases. However, very little is known about ILB populations that stably express Ig molecules and rapidly secrete innate cytokines, and how they may play into the dynamics of HIV transmission, disease progression, and treatment and preventive strategies. Herein, we present several seminal findings: identification of a cellular phenotype in multiple macaque and human tissues bearing verifiable features of both B cells and natural killer cells; expansion of putative NKB cells in the mucosae of chronically SIV-infected macaques; and a lentivirus-driven shift in immunoglobulin expression on NKB cells.

Whether NKB cells truly represent a stable independent cell has been heavily debated. Although multiple future studies will be required to scrutinize this cell type, we do present several findings that support its existence. Phenotypically, CD3CD20+ cells expressing natural killer cell-specific markers were found in multiple tissues of two different primate species. These findings could possibly be explained by membrane exchange or nonspecific antibody binding. However, our demonstration of NKG2A/C transcripts in these cells makes that extremely unlikely. Beyond that, it remains unclear whether NKB cells are more closely related to B cells or natural killer cells. The diverse and high-level expression of multiple Ig molecules, as well as CD40 and HLA-DR, suggest NKB cells are more like B cells, but the intermediate levels of granzyme B could suggest these cells may also have cytolytic properties.

One of the most striking findings in this study was an overall expansion of NKB in circulation and in the colon during chronic SIV infection. Scientifically this may not be surprising, given the high level of virus replication and cell death in the gastrointestinal tract, coupled with the putative role of NKB cells as rapid responders to infectious pathogens. The expansion did not however, correlate with virus loads, and no expansion was observed in the circulation of HIV-1-infected patients. This could be attributed, at least in part, to species differences, the fact that human colorectal samples could not be analyzed in this cohort where the expansion was more striking, or that NKB are most sensitive to sites of very high inflammation. It is also likely that the large differences in viral loads between SIV-infected macaques and HIV-infected humans in this study (>1 log) contributed to this distinction. SIV set points are traditionally much greater than in HIV-infected humans [28] and this study was not powered to address these types of differences. Another unique finding was the virus-induced alteration in Ig expression. It is tempting to speculate that the stable innate IgM and IgA expression shifting to IgG may reflect NKB cell plasticity and a novel switch from innate to adaptive immunity. Interestingly though IgG upregulation was significant in macaques but not in humans. Again as the increase was most prominent in tissues (which were not available from HIV-infected persons), this may not fully reflect the state of the cells in infection, but could also be a species or virus difference.

We acknowledge that the findings and theoretical niche of NKB cells remain controversial, but we present our findings, as they are to help further the resolution of this unexpected finding. Our data suggest that the NKB cell phenotype, regardless of unknown ontogeny is likely a real one. However, much as was previously suggested [17], we speculate NKB cells are a subpopulation of B cells that unexpectedly shares some properties overlapping with natural killer cells, the functional reasons for which remain unclear. Strikingly these cells are also significantly perturbed during lentivirus infection. Future studies will be needed to address the mechanism behind these phenomena in tissues of humans and macaques in both early and late infections.


The authors thank the CVVR flow cytometry core and Michelle Lifton for expert technical assistance. This work was supported by National Institutes of Health grants P01 AI120756, R01 DE026014, R01 DE026327, R01 AI20828 (all to R.K.R.), and the Harvard Center for AIDS Research grant P30 AI060354.

C.M. and C.N. contributed equally to this work

Author contributions: Role of each of the authors in the study: R.K.R. designed the study and acquired funding. C.M., C.N., K.K., and S.V.S. performed most of the flow cytometric assays and associated analyses. D.R.R. performed the RNA-flow assays. S.S., R.J., B.H., K.K., and V.V. acquired and processed all samples. P.G. and S.J. provided clinical patient samples, clinical data and interpretation. R.K.R., C.M., and C.N. wrote the article with assistance from all co-authors.

Funding acknowledgement: This work was supported by National Institutes of Health grants P01 AI120756, R01 DE026014, R01 DE026327, R01 AI20828 (all to R.K.R.), and the Harvard Center for AIDS Research grant P30 AI060354.

Conflicts of interest

There are no conflicts of interest.


1. Baumgarth N. Innate-like B cells and their rules of engagement. Adv Exp Med Biol 2013; 785:57–66.
2. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 2013; 13:118–132.
3. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5:606–616.
4. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14:617–629.
5. Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, et al. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007; 178:7531–7539.
6. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286:2156–2159.
7. Geherin SA, Gomez D, Glabman RA, Ruthel G, Hamann A, Debes GF. IL-10+ innate-like B cells are part of the skin immune system and require alpha4beta1 integrin to migrate between the peritoneum and inflamed skin. J Immunol 2016; 196:2514–2525.
8. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 1987; 236:77–81.
9. Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol 1992; 148:2690–2702.
10. Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A 2009; 106:13451–13456.
11. Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, Tassandin C, et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS 2005; 19:1947–1955.
12. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, Atlas A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580–1587.
13. Moir S, Fauci AS. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunol Rev 2013; 254:207–224.
14. Carrillo J, Negredo E, Puig J, Molinos-Albert LM, Rodriguez de la Concepcion ML, Curriu M, et al. Memory B cell dysregulation in HIV-1-infected individuals. AIDS 2018; 32:149–160.
15. Lopez-Abente J, Prieto-Sanchez A, Munoz-Fernandez MA, Correa-Rocha R, Pion M. Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro. Cell Mol Immunol 2017; [Epub ahead of print].
16. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural killer-like B cells prime innate lymphocytes against microbial infection. Immunity 2016; 45:131–144.
17. Kerdiles YM, Almeida FF, Thompson T, Chopin M, Vienne M, Bruhns P, et al. Natural-killer-like B cells display the phenotypic and functional characteristics of conventional B cells. Immunity 2017; 47:199–200.
18. Wang S, Xia P, Fan Z. Natural-killer-like B cells function as a separate subset of innate B cells. Immunity 2017; 47:201–202.
19. Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of postcytometric complex multivariate datasets. Cytometry A 2011; 79A:167–174.
20. Shah SV, Manickam C, Ram DR, Reeves RK. Innate lymphoid cells in HIV/SIV infections. Front Immunol 2017; 8:1818.
21. Li H, Goepfert P, Reeves RK. Short communication: plasmacytoid dendritic cells from HIV-1 elite controllers maintain a gut-homing phenotype associated with immune activation. AIDS Res Hum Retroviruses 2014; 30:1213–1215.
22. Whitney JB, Hill AL, Sanisetty S, Penaloza-MacMaster P, Liu J, Shetty M, et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 2014; 512:74–77.
23. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, Johnson RP. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 2010; 115:4439–4446.
24. Baumgarth N. B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production. Front Immunol 2016; 7:324.
25. Zulu MZ, Naidoo KK, Mncube Z, Jaggernath M, Goulder PJR, Ndung’u T, et al. Reduced expression of Siglec-7, NKG2A, and CD57 on terminally differentiated CD56(-)CD16(+) natural killer cell subset is associated with natural killer cell dysfunction in chronic HIV-1 clade C infection. AIDS Res Hum Retroviruses 2017; 33:1205–1213.
26. Mikulak J, Oriolo F, Zaghi E, Di Vito C, Mavilio D. Natural killer cells in HIV-1 infection and therapy. AIDS 2017; 31:2317–2330.
27. Demberg T, Brocca-Cofano E, Xiao P, Venzon D, Vargas-Inchaustegui D, Lee EM, et al. Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J Virol 2012; 86:12591–12604.
28. Shedlock DJ, Silvestri G, Weiner DB. Monkeying around with HIV vaccines: using rhesus macaques to define ’gatekeepers’ for clinical trials. Nat Rev Immunol 2009; 9:717–728.

B cell; innate immunity; macaques; natural killer cell; simian immunodeficiency virus

Supplemental Digital Content

Copyright © 2018 Wolters Kluwer Health, Inc.